共 50 条
Gastrointestinal manifestations of Behcet's disease: advances in evaluation and management
被引:0
|作者:
Vaiopoulos, A. G.
[1
]
Sfikakis, P. P.
[1
]
Kanakis, M. A.
[1
]
Vaiopoulos, G.
[2
]
Kaklamanis, P. G.
[3
]
机构:
[1] Univ Athens, Sch Med, Rheumatol Unit, Dept Propaedeut & Internal Med 1, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Expt Physiol, GR-11527 Athens, Greece
[3] Athens Med Ctr, Athens, Greece
关键词:
Behcet's;
apthous ulcer;
gastrointestinal manifestations;
therapy;
Crohn's disease;
anti-TNF;
BUDD-CHIARI-SYNDROME;
DAGGER-ETS DISEASE;
SACCHAROMYCES-CEREVISIAE ANTIBODIES;
TERM CLINICAL-OUTCOMES;
FACTOR-ALPHA ANTIBODY;
ESOPHAGEAL INVOLVEMENT;
INTESTINAL INVOLVEMENT;
COLONOSCOPIC FINDINGS;
HELICOBACTER-PYLORI;
PROGNOSTIC-FACTORS;
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Behcet's disease is a chronic, recurrent, inflammatory disorder characterised by orogenital ulcers and skin lesions; serious manifestations also include ocular, large vessel, gastrointestinal and neurological involvement. Genetic and unknown environmental factors customise the wide clinical expression of the disease. Gastrointestinal involvement is not unusual, albeit with a highly variable frequency among different ethnic populations. However, given the fact that gastrointestinal symptoms such as reflux, bleeding, diarrhoea are common in the general population, their clinical significance needs to be carefully interpreted. Apart from mouth the ileocecal area is typically involved, but inflammatory and/or vasculitic lesions may affect any part of the gastrointestinal tract. Complications such as perforation carry high morbidity rates and even mortality. Herein, we review all available information pertinent to gastrointestinal involvement of Behcet's disease and discuss the published advances in evaluation and its empirical management, including anti-TNF biologic therapies.
引用
收藏
页码:S140 / S148
页数:9
相关论文